Combined effects of epirubicin and tamoxifen on the cell-cycle phases in estrogen-receptor-negative Ehrlich ascites tumor cells
β Scribed by Adnan Aydiner; Mustafa Ridvanogullari; Dogan Anil; Erkan Topuz; Rustem Nurten; Rian Disci
- Publisher
- Springer-Verlag
- Year
- 1997
- Tongue
- English
- Weight
- 549 KB
- Volume
- 123
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We have compared the effects of a broad range of clinically relevant concentrations (0.1 to 10 M) of the steroidal pure anti-estrogen ICI 182,780 and the non-steroidal partial antiestrogen tamoxifen (TAM) on cell proliferation and induction of apoptosis in the estrogen receptor (ER)-negative ovarian
Eleven squamous-cell carcinoma (SCC) cell lines derived noma (SCC) cell lines derived from patients with head and from patients with head and neck cancer were tested together neck cancer (Virolainen et al., 1984). In that study, most of inhibition by tamoxifen. MCF-7 is known t o contain cytosolic e